

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.67610828 |
| 2 | regulation of gene silencing by miRNA (GO:0060964) | 4.67610828 |
| 3 | regulation of gene silencing by RNA (GO:0060966) | 4.67610828 |
| 4 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.21792023 |
| 5 | formation of translation preinitiation complex (GO:0001731) | 4.15330017 |
| 6 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 4.06900676 |
| 7 | response to peptidoglycan (GO:0032494) | 4.06307037 |
| 8 | regulation of SMAD protein import into nucleus (GO:0060390) | 4.00516611 |
| 9 | IMP biosynthetic process (GO:0006188) | 3.65062456 |
| 10 | paraxial mesoderm development (GO:0048339) | 3.56120501 |
| 11 | protein localization to endosome (GO:0036010) | 3.52833910 |
| 12 | pinocytosis (GO:0006907) | 3.52650192 |
| 13 | detection of molecule of bacterial origin (GO:0032490) | 3.50398914 |
| 14 | barbed-end actin filament capping (GO:0051016) | 3.48350124 |
| 15 | basement membrane organization (GO:0071711) | 3.46097080 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.40340184 |
| 17 | glycosphingolipid catabolic process (GO:0046479) | 3.38464335 |
| 18 | regulation of hippo signaling (GO:0035330) | 3.37425104 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.36994579 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.35093897 |
| 21 | detection of other organism (GO:0098543) | 3.31316555 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.28243057 |
| 23 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.18771529 |
| 24 | detection of external biotic stimulus (GO:0098581) | 3.17796976 |
| 25 | IMP metabolic process (GO:0046040) | 3.17081036 |
| 26 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16892015 |
| 27 | mannose metabolic process (GO:0006013) | 3.14266988 |
| 28 | regulation of mast cell degranulation (GO:0043304) | 3.12795978 |
| 29 | regulation of translational fidelity (GO:0006450) | 3.11851412 |
| 30 | detection of bacterium (GO:0016045) | 3.11084024 |
| 31 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.08809595 |
| 32 | nucleobase biosynthetic process (GO:0046112) | 3.08355206 |
| 33 | regulation of leukocyte degranulation (GO:0043300) | 3.05926693 |
| 34 | amino sugar catabolic process (GO:0046348) | 3.04989213 |
| 35 | maturation of SSU-rRNA (GO:0030490) | 3.03111145 |
| 36 | regulation of early endosome to late endosome transport (GO:2000641) | 3.02554701 |
| 37 | glycolipid catabolic process (GO:0019377) | 3.02319957 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.01501777 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.01501777 |
| 40 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.00342014 |
| 41 | nodal signaling pathway (GO:0038092) | 2.99174159 |
| 42 | heterochromatin organization (GO:0070828) | 2.98237264 |
| 43 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95840962 |
| 44 | oligosaccharide catabolic process (GO:0009313) | 2.94995590 |
| 45 | embryonic process involved in female pregnancy (GO:0060136) | 2.94884653 |
| 46 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.89266968 |
| 47 | outer ear morphogenesis (GO:0042473) | 2.89248885 |
| 48 | positive regulation of extracellular matrix organization (GO:1903055) | 2.85839651 |
| 49 | NADPH regeneration (GO:0006740) | 2.85403917 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 2.84928488 |
| 51 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.84008216 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83588664 |
| 53 | regulation of helicase activity (GO:0051095) | 2.81722781 |
| 54 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.80002971 |
| 55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.78321269 |
| 56 | purine nucleobase biosynthetic process (GO:0009113) | 2.77186679 |
| 57 | detection of biotic stimulus (GO:0009595) | 2.77158366 |
| 58 | regulation of superoxide anion generation (GO:0032928) | 2.76785526 |
| 59 | tetrahydrofolate metabolic process (GO:0046653) | 2.76050457 |
| 60 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.75229476 |
| 61 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.75228776 |
| 62 | stress fiber assembly (GO:0043149) | 2.72771715 |
| 63 | intestinal epithelial cell development (GO:0060576) | 2.71542573 |
| 64 | response to thyroid hormone (GO:0097066) | 2.71460012 |
| 65 | amyloid precursor protein catabolic process (GO:0042987) | 2.69949007 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 2.69853993 |
| 67 | DNA unwinding involved in DNA replication (GO:0006268) | 2.69052514 |
| 68 | pentose-phosphate shunt (GO:0006098) | 2.68806481 |
| 69 | response to muramyl dipeptide (GO:0032495) | 2.68097566 |
| 70 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.67812702 |
| 71 | response to laminar fluid shear stress (GO:0034616) | 2.67055168 |
| 72 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.66830435 |
| 73 | N-acetylneuraminate metabolic process (GO:0006054) | 2.66350282 |
| 74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.66160412 |
| 75 | response to host (GO:0075136) | 2.66160412 |
| 76 | response to host defenses (GO:0052200) | 2.66160412 |
| 77 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.65551988 |
| 78 | positive regulation of leukocyte degranulation (GO:0043302) | 2.65544342 |
| 79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.65261511 |
| 80 | apoptotic process involved in morphogenesis (GO:0060561) | 2.63789561 |
| 81 | endosome to melanosome transport (GO:0035646) | 2.62646770 |
| 82 | endosome to pigment granule transport (GO:0043485) | 2.62646770 |
| 83 | positive regulation of receptor recycling (GO:0001921) | 2.62186703 |
| 84 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.61292534 |
| 85 | anterior/posterior axis specification, embryo (GO:0008595) | 2.59872498 |
| 86 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.59448848 |
| 87 | response to host immune response (GO:0052572) | 2.59448848 |
| 88 | granulocyte activation (GO:0036230) | 2.58202141 |
| 89 | modulation by symbiont of host cellular process (GO:0044068) | 2.58180572 |
| 90 | glycine metabolic process (GO:0006544) | 2.57291497 |
| 91 | histone H2A monoubiquitination (GO:0035518) | 2.53771673 |
| 92 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.53546327 |
| 93 | hyaluronan catabolic process (GO:0030214) | 2.52852265 |
| 94 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.52198398 |
| 95 | positive regulation of protein homooligomerization (GO:0032464) | 2.51628219 |
| 96 | ceramide catabolic process (GO:0046514) | 2.50164888 |
| 97 | regulation of extracellular matrix disassembly (GO:0010715) | 2.49751703 |
| 98 | alpha-linolenic acid metabolic process (GO:0036109) | 2.46647596 |
| 99 | DNA strand elongation (GO:0022616) | 2.45301484 |
| 100 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.45040025 |
| 101 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.44532403 |
| 102 | apoptotic cell clearance (GO:0043277) | 2.44495051 |
| 103 | proline biosynthetic process (GO:0006561) | 2.44159631 |
| 104 | regulation of chemokine secretion (GO:0090196) | 2.43981458 |
| 105 | DNA replication initiation (GO:0006270) | 2.43295049 |
| 106 | macrophage activation (GO:0042116) | 2.43059734 |
| 107 | metanephric mesenchyme development (GO:0072075) | 2.42609368 |
| 108 | female genitalia development (GO:0030540) | 2.41571275 |
| 109 | kidney mesenchyme development (GO:0072074) | 2.41426956 |
| 110 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.40775189 |
| 111 | low-density lipoprotein particle clearance (GO:0034383) | 2.40007058 |
| 112 | establishment of apical/basal cell polarity (GO:0035089) | 2.39928711 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 2.39815470 |
| 114 | nuclear pore organization (GO:0006999) | 2.39750424 |
| 115 | pre-miRNA processing (GO:0031054) | 2.38691156 |
| 116 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 2.38160413 |
| 117 | ribosomal small subunit assembly (GO:0000028) | 2.37615084 |
| 118 | mitotic nuclear envelope disassembly (GO:0007077) | 2.37075008 |
| 119 | cellular extravasation (GO:0045123) | 2.36570116 |
| 120 | trophectodermal cell differentiation (GO:0001829) | 2.36240354 |
| 121 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.35865264 |
| 122 | neutrophil activation (GO:0042119) | 2.35789229 |
| 123 | vagina development (GO:0060068) | 2.35170529 |
| 124 | peptide catabolic process (GO:0043171) | 2.34986545 |
| 125 | regulation of regulated secretory pathway (GO:1903305) | 2.33749520 |
| 126 | regulation of translation in response to stress (GO:0043555) | 2.33708392 |
| 127 | germinal center formation (GO:0002467) | 2.33157566 |
| 128 | organ regeneration (GO:0031100) | 2.33147907 |
| 129 | positive regulation of mast cell activation (GO:0033005) | 2.32293062 |
| 130 | maternal placenta development (GO:0001893) | 2.32258256 |
| 131 | COPI coating of Golgi vesicle (GO:0048205) | 2.32028046 |
| 132 | Golgi transport vesicle coating (GO:0048200) | 2.32028046 |
| 133 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.31889163 |
| 134 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.31652975 |
| 135 | positive regulation of mast cell degranulation (GO:0043306) | 2.31652975 |
| 136 | T cell apoptotic process (GO:0070231) | 2.31493559 |
| 137 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.31359066 |
| 138 | myeloid dendritic cell differentiation (GO:0043011) | 2.29600128 |
| 139 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.28148708 |
| 140 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.28073419 |
| 141 | folic acid metabolic process (GO:0046655) | 2.27685607 |
| 142 | regulation of gene silencing (GO:0060968) | 2.27621011 |
| 143 | regulation of cholesterol storage (GO:0010885) | 2.27291054 |
| 144 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.25635355 |
| 145 | embryonic placenta development (GO:0001892) | 2.24920387 |
| 146 | ribosome biogenesis (GO:0042254) | 2.24784426 |
| 147 | nucleoside salvage (GO:0043174) | 2.24048550 |
| 148 | viral transcription (GO:0019083) | 2.23807472 |
| 149 | translational initiation (GO:0006413) | 2.23690594 |
| 150 | positive regulation by symbiont of host defense response (GO:0052509) | 2.23598038 |
| 151 | modulation by symbiont of host defense response (GO:0052031) | 2.23598038 |
| 152 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.23598038 |
| 153 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.23598038 |
| 154 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.23598038 |
| 155 | modulation by symbiont of host immune response (GO:0052553) | 2.23598038 |
| 156 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.22707520 |
| 157 | cytidine deamination (GO:0009972) | 2.22618116 |
| 158 | cytidine metabolic process (GO:0046087) | 2.22618116 |
| 159 | cytidine catabolic process (GO:0006216) | 2.22618116 |
| 160 | tRNA aminoacylation for protein translation (GO:0006418) | 2.22250710 |
| 161 | myeloid cell activation involved in immune response (GO:0002275) | 2.22200531 |
| 162 | positive regulation of chemokine secretion (GO:0090197) | 2.22098304 |
| 163 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.22057310 |
| 164 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.22053690 |
| 165 | regulation of extracellular matrix organization (GO:1903053) | 2.21637095 |
| 166 | positive regulation of type 2 immune response (GO:0002830) | 2.20974519 |
| 167 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.20010855 |
| 168 | folic acid-containing compound metabolic process (GO:0006760) | 2.19393630 |
| 169 | cranial suture morphogenesis (GO:0060363) | 2.19198912 |
| 170 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.18786849 |
| 171 | response to UV-C (GO:0010225) | 2.18609737 |
| 172 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.18511369 |
| 173 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.18262895 |
| 174 | UMP biosynthetic process (GO:0006222) | 2.18262895 |
| 175 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.18262895 |
| 176 | UMP metabolic process (GO:0046049) | 2.18262895 |
| 177 | nuclear envelope disassembly (GO:0051081) | 2.18246402 |
| 178 | membrane disassembly (GO:0030397) | 2.18246402 |
| 179 | regulation of integrin activation (GO:0033623) | 2.17845179 |
| 180 | positive regulation of phagocytosis (GO:0050766) | 2.17826425 |
| 181 | glyoxylate metabolic process (GO:0046487) | 2.17748337 |
| 182 | amino acid activation (GO:0043038) | 2.15958786 |
| 183 | tRNA aminoacylation (GO:0043039) | 2.15958786 |
| 184 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.14621599 |
| 185 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.13616796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.19527175 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.62833353 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.08726312 |
| 4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.98998732 |
| 5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.98998732 |
| 6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.98998732 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.97622535 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.62613099 |
| 9 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.62576135 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.61645600 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.30341126 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.24633058 |
| 13 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.17191346 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12183792 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12113143 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11122753 |
| 17 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.08727167 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.04817483 |
| 19 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.01255220 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.00673270 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98735200 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.98226906 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.97811845 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.94968904 |
| 25 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.94678464 |
| 26 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.92052938 |
| 27 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.84508815 |
| 28 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.79931360 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.79565094 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79280251 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.79099039 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78038955 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.74648673 |
| 34 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.74262001 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73665004 |
| 36 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.73135067 |
| 37 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72494822 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69627238 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66718218 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66144967 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61890446 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.59583566 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58504792 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57233488 |
| 45 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56174610 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.55897846 |
| 47 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.53396027 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52171966 |
| 49 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.49995884 |
| 50 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.49583761 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47689946 |
| 52 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.45828916 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44851185 |
| 54 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44386671 |
| 55 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44075147 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.40957902 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.40949941 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40831827 |
| 59 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.39261579 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37859301 |
| 61 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37767012 |
| 62 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.37444291 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37252244 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36846911 |
| 65 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34934087 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.33117323 |
| 67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32854113 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32706950 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32481608 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.32439504 |
| 71 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.31114770 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31058358 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30029680 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30011532 |
| 75 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.29362177 |
| 76 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.28659203 |
| 77 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28494038 |
| 78 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28395180 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28096998 |
| 80 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.27737906 |
| 81 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.27566851 |
| 82 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27096003 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26837111 |
| 84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25896232 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25725064 |
| 86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25575978 |
| 87 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.25243495 |
| 88 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.25232025 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25202840 |
| 90 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24930134 |
| 91 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.24874432 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24128660 |
| 93 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.24113815 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23757541 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23633335 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23569786 |
| 97 | MAF_26560356_Chip-Seq_TH2_Human | 1.23280146 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23177172 |
| 99 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21665942 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 1.21480942 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21418994 |
| 102 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20759750 |
| 103 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20464709 |
| 104 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20407854 |
| 105 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20250829 |
| 106 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20015849 |
| 107 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.19518940 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19359506 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19355389 |
| 110 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19001414 |
| 111 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.18483014 |
| 112 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17916918 |
| 113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17915984 |
| 114 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.16865309 |
| 115 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.16776940 |
| 116 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16767903 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15725127 |
| 118 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.15665964 |
| 119 | ATF3_27146783_Chip-Seq_COLON_Human | 1.15537896 |
| 120 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15182277 |
| 121 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14916251 |
| 122 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14576394 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14560147 |
| 124 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14107187 |
| 125 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13647244 |
| 126 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12687744 |
| 127 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12530110 |
| 128 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11665204 |
| 129 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11589706 |
| 130 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.11230636 |
| 131 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.10408314 |
| 132 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10043201 |
| 133 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09516202 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09392870 |
| 135 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08663737 |
| 136 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08282636 |
| 137 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08114807 |
| 138 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.07328998 |
| 139 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06333232 |
| 140 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05419682 |
| 141 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.05410730 |
| 142 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.05188736 |
| 143 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.04770195 |
| 144 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.04127211 |
| 145 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03799934 |
| 146 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.03714116 |
| 147 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.03064513 |
| 148 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02968228 |
| 149 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.02662654 |
| 150 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02499445 |
| 151 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02258261 |
| 152 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00861736 |
| 153 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00681656 |
| 154 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00656183 |
| 155 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99769647 |
| 156 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99700830 |
| 157 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98653513 |
| 158 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98370302 |
| 159 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98352468 |
| 160 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.98131190 |
| 161 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97684456 |
| 162 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96017142 |
| 163 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.95852521 |
| 164 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.95778475 |
| 165 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94849385 |
| 166 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94383341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.49767164 |
| 2 | MP0009840_abnormal_foam_cell | 3.47531341 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.94296765 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.87195763 |
| 5 | MP0005451_abnormal_body_composition | 2.76648445 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.74642047 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.52673908 |
| 8 | MP0008260_abnormal_autophagy | 2.48395203 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.46877818 |
| 10 | MP0003724_increased_susceptibility_to | 2.46531182 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.28376979 |
| 12 | MP0002419_abnormal_innate_immunity | 2.19189967 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.18678542 |
| 14 | MP0003567_abnormal_fetal_cardiomyocyte | 2.08173887 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.05295230 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 1.93133204 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 1.89609285 |
| 18 | MP0005025_abnormal_response_to | 1.87333446 |
| 19 | MP0001533_abnormal_skeleton_physiology | 1.84842221 |
| 20 | MP0000685_abnormal_immune_system | 1.84244225 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.79392334 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.78536627 |
| 23 | MP0005023_abnormal_wound_healing | 1.75484752 |
| 24 | MP0009785_altered_susceptibility_to | 1.74947392 |
| 25 | MP0005670_abnormal_white_adipose | 1.71271853 |
| 26 | MP0003453_abnormal_keratinocyte_physiol | 1.68239620 |
| 27 | MP0003075_altered_response_to | 1.67070803 |
| 28 | MP0004510_myositis | 1.66672094 |
| 29 | MP0005000_abnormal_immune_tolerance | 1.65699912 |
| 30 | MP0000604_amyloidosis | 1.64709951 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.61585101 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.61072236 |
| 33 | MP0003941_abnormal_skin_development | 1.59608827 |
| 34 | MP0005387_immune_system_phenotype | 1.58654447 |
| 35 | MP0001790_abnormal_immune_system | 1.58654447 |
| 36 | MP0010307_abnormal_tumor_latency | 1.57725094 |
| 37 | MP0004947_skin_inflammation | 1.56679214 |
| 38 | MP0002877_abnormal_melanocyte_morpholog | 1.56149855 |
| 39 | MP0002163_abnormal_gland_morphology | 1.53976672 |
| 40 | MP0004133_heterotaxia | 1.53042192 |
| 41 | MP0003693_abnormal_embryo_hatching | 1.51054610 |
| 42 | MP0004858_abnormal_nervous_system | 1.50784551 |
| 43 | MP0004272_abnormal_basement_membrane | 1.44388846 |
| 44 | MP0003111_abnormal_nucleus_morphology | 1.41762961 |
| 45 | MP0000371_diluted_coat_color | 1.41438023 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.41353190 |
| 47 | MP0003828_pulmonary_edema | 1.38652402 |
| 48 | MP0002723_abnormal_immune_serum | 1.36815418 |
| 49 | MP0001730_embryonic_growth_arrest | 1.36697384 |
| 50 | MP0008007_abnormal_cellular_replicative | 1.35494314 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.32624095 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.31409833 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.31208247 |
| 54 | MP0003077_abnormal_cell_cycle | 1.31039247 |
| 55 | MP0008057_abnormal_DNA_replication | 1.30924267 |
| 56 | MP0002086_abnormal_extraembryonic_tissu | 1.27429112 |
| 57 | MP0003186_abnormal_redox_activity | 1.26771093 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.25668547 |
| 59 | MP0008469_abnormal_protein_level | 1.25560659 |
| 60 | MP0001819_abnormal_immune_cell | 1.25218480 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.25157372 |
| 62 | MP0009278_abnormal_bone_marrow | 1.25056748 |
| 63 | MP0009053_abnormal_anal_canal | 1.23900723 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.22858530 |
| 65 | MP0006138_congestive_heart_failure | 1.22020615 |
| 66 | MP0001915_intracranial_hemorrhage | 1.22008278 |
| 67 | MP0002132_abnormal_respiratory_system | 1.21790900 |
| 68 | MP0001800_abnormal_humoral_immune | 1.20978236 |
| 69 | MP0005409_darkened_coat_color | 1.20347846 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.19776219 |
| 71 | MP0003300_gastrointestinal_ulcer | 1.19700040 |
| 72 | MP0003329_amyloid_beta_deposits | 1.18964888 |
| 73 | MP0002405_respiratory_system_inflammati | 1.15984189 |
| 74 | MP0005365_abnormal_bile_salt | 1.15902632 |
| 75 | MP0004197_abnormal_fetal_growth/weight/ | 1.15445690 |
| 76 | MP0005257_abnormal_intraocular_pressure | 1.15158403 |
| 77 | MP0006054_spinal_hemorrhage | 1.11875478 |
| 78 | MP0003448_altered_tumor_morphology | 1.11367147 |
| 79 | MP0005380_embryogenesis_phenotype | 1.11127081 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 1.11127081 |
| 81 | MP0008004_abnormal_stomach_pH | 1.09775473 |
| 82 | MP0001697_abnormal_embryo_size | 1.09620476 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 1.08807814 |
| 84 | MP0000733_abnormal_muscle_development | 1.08735327 |
| 85 | MP0000350_abnormal_cell_proliferation | 1.08039823 |
| 86 | MP0003984_embryonic_growth_retardation | 1.07827354 |
| 87 | MP0000858_altered_metastatic_potential | 1.07728309 |
| 88 | MP0002088_abnormal_embryonic_growth/wei | 1.07175328 |
| 89 | MP0005623_abnormal_meninges_morphology | 1.06136161 |
| 90 | MP0010630_abnormal_cardiac_muscle | 1.05731176 |
| 91 | MP0009764_decreased_sensitivity_to | 1.05045380 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 1.04953124 |
| 93 | MP0005671_abnormal_response_to | 1.04124143 |
| 94 | MP0003690_abnormal_glial_cell | 1.03735851 |
| 95 | MP0005164_abnormal_response_to | 1.02216854 |
| 96 | MP0000343_altered_response_to | 1.01742751 |
| 97 | MP0003279_aneurysm | 1.01327516 |
| 98 | MP0002080_prenatal_lethality | 1.00425057 |
| 99 | MP0008058_abnormal_DNA_repair | 1.00073542 |
| 100 | MP0000598_abnormal_liver_morphology | 0.99763973 |
| 101 | MP0002277_abnormal_respiratory_mucosa | 0.98259899 |
| 102 | MP0005360_urolithiasis | 0.96990859 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.94763633 |
| 104 | MP0005166_decreased_susceptibility_to | 0.94031932 |
| 105 | MP0005390_skeleton_phenotype | 0.93754387 |
| 106 | MP0002269_muscular_atrophy | 0.93353044 |
| 107 | MP0010094_abnormal_chromosome_stability | 0.92694949 |
| 108 | MP0001851_eye_inflammation | 0.90734381 |
| 109 | MP0002085_abnormal_embryonic_tissue | 0.89578685 |
| 110 | MP0002925_abnormal_cardiovascular_devel | 0.89576232 |
| 111 | MP0006082_CNS_inflammation | 0.87947274 |
| 112 | MP0000767_abnormal_smooth_muscle | 0.87671587 |
| 113 | MP0000716_abnormal_immune_system | 0.87573016 |
| 114 | MP0002139_abnormal_hepatobiliary_system | 0.87301020 |
| 115 | MP0005367_renal/urinary_system_phenotyp | 0.87056447 |
| 116 | MP0000516_abnormal_urinary_system | 0.87056447 |
| 117 | MP0004233_abnormal_muscle_weight | 0.86842062 |
| 118 | MP0001175_abnormal_lung_morphology | 0.86441044 |
| 119 | MP0002295_abnormal_pulmonary_circulatio | 0.85560118 |
| 120 | MP0003283_abnormal_digestive_organ | 0.85281164 |
| 121 | MP0001958_emphysema | 0.83832920 |
| 122 | MP0001544_abnormal_cardiovascular_syste | 0.83561425 |
| 123 | MP0005385_cardiovascular_system_phenoty | 0.83561425 |
| 124 | MP0005310_abnormal_salivary_gland | 0.83557112 |
| 125 | MP0004381_abnormal_hair_follicle | 0.83290829 |
| 126 | MP0005408_hypopigmentation | 0.82795180 |
| 127 | MP0003436_decreased_susceptibility_to | 0.82665249 |
| 128 | MP0000609_abnormal_liver_physiology | 0.81915302 |
| 129 | MP0004883_abnormal_blood_vessel | 0.81867746 |
| 130 | MP0002084_abnormal_developmental_patter | 0.81820678 |
| 131 | MP0000015_abnormal_ear_pigmentation | 0.81392656 |
| 132 | MP0008932_abnormal_embryonic_tissue | 0.81339839 |
| 133 | MP0001853_heart_inflammation | 0.81278406 |
| 134 | MP0001849_ear_inflammation | 0.81109216 |
| 135 | MP0005085_abnormal_gallbladder_physiolo | 0.80933865 |
| 136 | MP0002128_abnormal_blood_circulation | 0.80818042 |
| 137 | MP0003795_abnormal_bone_structure | 0.79841599 |
| 138 | MP0002135_abnormal_kidney_morphology | 0.79520341 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.78623812 |
| 140 | MP0002254_reproductive_system_inflammat | 0.77744581 |
| 141 | MP0009643_abnormal_urine_homeostasis | 0.77334220 |
| 142 | MP0003091_abnormal_cell_migration | 0.76704393 |
| 143 | MP0005165_increased_susceptibility_to | 0.76368844 |
| 144 | MP0000249_abnormal_blood_vessel | 0.76260818 |
| 145 | MP0000920_abnormal_myelination | 0.75959897 |
| 146 | MP0002429_abnormal_blood_cell | 0.75807683 |
| 147 | MP0005379_endocrine/exocrine_gland_phen | 0.75597268 |
| 148 | MP0002933_joint_inflammation | 0.75551136 |
| 149 | MP0002398_abnormal_bone_marrow | 0.75512401 |
| 150 | MP0000428_abnormal_craniofacial_morphol | 0.74648202 |
| 151 | MP0001614_abnormal_blood_vessel | 0.74646379 |
| 152 | MP0005397_hematopoietic_system_phenotyp | 0.74158574 |
| 153 | MP0001545_abnormal_hematopoietic_system | 0.74158574 |
| 154 | MP0000313_abnormal_cell_death | 0.73588163 |
| 155 | MP0005266_abnormal_metabolism | 0.71817842 |
| 156 | MP0003878_abnormal_ear_physiology | 0.71817583 |
| 157 | MP0005377_hearing/vestibular/ear_phenot | 0.71817583 |
| 158 | MP0010234_abnormal_vibrissa_follicle | 0.71218009 |
| 159 | MP0003890_abnormal_embryonic-extraembry | 0.71197433 |
| 160 | MP0008874_decreased_physiological_sensi | 0.70872988 |
| 161 | MP0001348_abnormal_lacrimal_gland | 0.70336394 |
| 162 | MP0009763_increased_sensitivity_to | 0.70160493 |
| 163 | MP0005197_abnormal_uvea_morphology | 0.68538094 |
| 164 | MP0003123_paternal_imprinting | 0.68501225 |
| 165 | MP0000613_abnormal_salivary_gland | 0.67813292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cochlea (HP:0000375) | 4.82260369 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.89135953 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.71592982 |
| 4 | Ileus (HP:0002595) | 3.50665709 |
| 5 | Axonal loss (HP:0003447) | 3.45832965 |
| 6 | Agnosia (HP:0010524) | 3.34540259 |
| 7 | Loss of speech (HP:0002371) | 3.32820942 |
| 8 | Multiple enchondromatosis (HP:0005701) | 3.28239418 |
| 9 | Cervical subluxation (HP:0003308) | 3.19761647 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.10453284 |
| 11 | Purpura (HP:0000979) | 3.01832037 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 2.95732244 |
| 13 | Morphological abnormality of the inner ear (HP:0011390) | 2.90813989 |
| 14 | Rectal prolapse (HP:0002035) | 2.80185893 |
| 15 | Deep venous thrombosis (HP:0002625) | 2.76525441 |
| 16 | Vertebral compression fractures (HP:0002953) | 2.72565072 |
| 17 | Esophageal varix (HP:0002040) | 2.71681050 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 2.68625135 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.67011059 |
| 20 | Mucopolysacchariduria (HP:0008155) | 2.67011059 |
| 21 | Amyloidosis (HP:0011034) | 2.63402097 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.60592835 |
| 23 | Nuclear cataract (HP:0100018) | 2.59268366 |
| 24 | Myositis (HP:0100614) | 2.58966723 |
| 25 | Myocardial infarction (HP:0001658) | 2.58616139 |
| 26 | Orchitis (HP:0100796) | 2.55930687 |
| 27 | Ependymoma (HP:0002888) | 2.53301486 |
| 28 | Dysostosis multiplex (HP:0000943) | 2.49996404 |
| 29 | Hemorrhage of the eye (HP:0011885) | 2.48475978 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45004376 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45004376 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45004376 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.41523102 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.38568285 |
| 35 | Obstructive lung disease (HP:0006536) | 2.38568285 |
| 36 | Gingivitis (HP:0000230) | 2.35940066 |
| 37 | Hand muscle atrophy (HP:0009130) | 2.34308084 |
| 38 | Neurofibrillary tangles (HP:0002185) | 2.28577122 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.28450526 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.27664216 |
| 41 | Personality changes (HP:0000751) | 2.27498913 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.26534504 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.25287119 |
| 44 | Premature rupture of membranes (HP:0001788) | 2.24785360 |
| 45 | Distal upper limb amyotrophy (HP:0007149) | 2.24642295 |
| 46 | Upper limb amyotrophy (HP:0009129) | 2.24642295 |
| 47 | Petechiae (HP:0000967) | 2.23822679 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.18839459 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.18278751 |
| 50 | Hematochezia (HP:0002573) | 2.18231602 |
| 51 | Ankle contracture (HP:0006466) | 2.16389902 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.14671224 |
| 53 | Polycythemia (HP:0001901) | 2.10722934 |
| 54 | Progressive neurologic deterioration (HP:0002344) | 2.10509141 |
| 55 | Cellulitis (HP:0100658) | 2.10080092 |
| 56 | Hepatosplenomegaly (HP:0001433) | 2.08452503 |
| 57 | Spinal muscular atrophy (HP:0007269) | 2.08436296 |
| 58 | Spastic diplegia (HP:0001264) | 2.07024891 |
| 59 | Gingival bleeding (HP:0000225) | 2.06169009 |
| 60 | Selective tooth agenesis (HP:0001592) | 2.04400841 |
| 61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.04265037 |
| 62 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.04265037 |
| 63 | Abnormality of glycolipid metabolism (HP:0010969) | 2.04265037 |
| 64 | Achilles tendon contracture (HP:0001771) | 2.03643044 |
| 65 | Abnormality of the Achilles tendon (HP:0005109) | 2.03455742 |
| 66 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.03144063 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.01426165 |
| 68 | Male infertility (HP:0003251) | 1.99702036 |
| 69 | Mesangial abnormality (HP:0001966) | 1.99230194 |
| 70 | Epistaxis (HP:0000421) | 1.98777514 |
| 71 | Increased connective tissue (HP:0009025) | 1.97895997 |
| 72 | Optic neuritis (HP:0100653) | 1.97329303 |
| 73 | Retrobulbar optic neuritis (HP:0100654) | 1.97329303 |
| 74 | Vaginal fistula (HP:0004320) | 1.97187498 |
| 75 | Thin bony cortex (HP:0002753) | 1.96895794 |
| 76 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96144500 |
| 77 | Increased serum ferritin (HP:0003281) | 1.94886102 |
| 78 | Hypoglycemic coma (HP:0001325) | 1.94802382 |
| 79 | Spondylolisthesis (HP:0003302) | 1.94320929 |
| 80 | Microretrognathia (HP:0000308) | 1.93353427 |
| 81 | Abnormality of the right ventricle (HP:0001707) | 1.92584328 |
| 82 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91867977 |
| 83 | Bone pain (HP:0002653) | 1.91525808 |
| 84 | Recurrent skin infections (HP:0001581) | 1.90605122 |
| 85 | Thoracic kyphosis (HP:0002942) | 1.90085804 |
| 86 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89516310 |
| 87 | Abnormal hemoglobin (HP:0011902) | 1.89098555 |
| 88 | Neuronal loss in central nervous system (HP:0002529) | 1.89019529 |
| 89 | Abnormal cartilage morphology (HP:0002763) | 1.88785212 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 1.88493193 |
| 91 | Astrocytoma (HP:0009592) | 1.88215158 |
| 92 | Abnormality of the astrocytes (HP:0100707) | 1.88215158 |
| 93 | Flat acetabular roof (HP:0003180) | 1.86516958 |
| 94 | Prolonged neonatal jaundice (HP:0006579) | 1.85974411 |
| 95 | Urticaria (HP:0001025) | 1.85594228 |
| 96 | Prolonged bleeding time (HP:0003010) | 1.85103043 |
| 97 | Abnormality of the salivary glands (HP:0010286) | 1.84278600 |
| 98 | Disinhibition (HP:0000734) | 1.83828802 |
| 99 | Rectovaginal fistula (HP:0000143) | 1.83812956 |
| 100 | Rectal fistula (HP:0100590) | 1.83812956 |
| 101 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.83474366 |
| 102 | Gastrointestinal dysmotility (HP:0002579) | 1.83215982 |
| 103 | Colon cancer (HP:0003003) | 1.82776786 |
| 104 | Polygenic inheritance (HP:0010982) | 1.82618046 |
| 105 | Upper motor neuron abnormality (HP:0002127) | 1.82003724 |
| 106 | Abnormality of the nasal mucosa (HP:0000433) | 1.81771144 |
| 107 | Mitral stenosis (HP:0001718) | 1.81766302 |
| 108 | Gastrointestinal carcinoma (HP:0002672) | 1.80586989 |
| 109 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.80586989 |
| 110 | Recurrent abscess formation (HP:0002722) | 1.80073441 |
| 111 | Abnormality of the thoracic spine (HP:0100711) | 1.79995379 |
| 112 | Supernumerary spleens (HP:0009799) | 1.79924574 |
| 113 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79796999 |
| 114 | Glomerulonephritis (HP:0000099) | 1.79712069 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.79257075 |
| 116 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.77898921 |
| 117 | Malnutrition (HP:0004395) | 1.77888440 |
| 118 | Autoimmune thrombocytopenia (HP:0001973) | 1.77518820 |
| 119 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.77193620 |
| 120 | Vertebral hypoplasia (HP:0008417) | 1.77124054 |
| 121 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.77124054 |
| 122 | Shallow orbits (HP:0000586) | 1.76398027 |
| 123 | Generalized amyotrophy (HP:0003700) | 1.76335412 |
| 124 | Xanthomatosis (HP:0000991) | 1.75849780 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.75742464 |
| 126 | Peritonitis (HP:0002586) | 1.74931864 |
| 127 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.74325285 |
| 128 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.74325285 |
| 129 | Single umbilical artery (HP:0001195) | 1.74325285 |
| 130 | Lymphangioma (HP:0100764) | 1.74110351 |
| 131 | Muscle fibrillation (HP:0010546) | 1.73703504 |
| 132 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.72775769 |
| 133 | Pathologic fracture (HP:0002756) | 1.72304418 |
| 134 | Complement deficiency (HP:0004431) | 1.72013040 |
| 135 | Abnormality of complement system (HP:0005339) | 1.70568879 |
| 136 | Increased IgE level (HP:0003212) | 1.70364317 |
| 137 | Hypertriglyceridemia (HP:0002155) | 1.69464252 |
| 138 | Partial duplication of the phalanx of hand (HP:0009999) | 1.68749735 |
| 139 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68092670 |
| 140 | Aortic aneurysm (HP:0004942) | 1.68031498 |
| 141 | Short humerus (HP:0005792) | 1.67769173 |
| 142 | Abnormal number of incisors (HP:0011064) | 1.67655109 |
| 143 | Aneurysm (HP:0002617) | 1.67468827 |
| 144 | Trismus (HP:0000211) | 1.67351018 |
| 145 | Cardiomegaly (HP:0001640) | 1.66444193 |
| 146 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.65989516 |
| 147 | Tongue fasciculations (HP:0001308) | 1.65574619 |
| 148 | Abnormal platelet function (HP:0011869) | 1.65387585 |
| 149 | Impaired platelet aggregation (HP:0003540) | 1.65387585 |
| 150 | Diminished motivation (HP:0000745) | 1.65296327 |
| 151 | J-shaped sella turcica (HP:0002680) | 1.65196979 |
| 152 | Supranuclear gaze palsy (HP:0000605) | 1.65041401 |
| 153 | Joint stiffness (HP:0001387) | 1.64680225 |
| 154 | Joint hemorrhage (HP:0005261) | 1.64653888 |
| 155 | Recurrent bacterial skin infections (HP:0005406) | 1.64154168 |
| 156 | Bulbar palsy (HP:0001283) | 1.63981819 |
| 157 | Exercise-induced muscle cramps (HP:0003710) | 1.63699504 |
| 158 | Blue sclerae (HP:0000592) | 1.63490847 |
| 159 | Abnormal neuron morphology (HP:0012757) | 1.62152313 |
| 160 | Abnormality of the motor neurons (HP:0002450) | 1.62152313 |
| 161 | Skin nodule (HP:0200036) | 1.60692487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 5.54478972 |
| 2 | TIE1 | 4.94700439 |
| 3 | IRAK3 | 3.14863898 |
| 4 | PRPF4B | 2.90258116 |
| 5 | ERN1 | 2.85167368 |
| 6 | TRIB3 | 2.60262448 |
| 7 | EPHA2 | 2.58559733 |
| 8 | BLK | 2.58421636 |
| 9 | PRKG2 | 2.45388547 |
| 10 | PKN2 | 2.44151945 |
| 11 | FLT3 | 2.20176571 |
| 12 | MAP3K11 | 2.14406592 |
| 13 | BUB1 | 2.08953994 |
| 14 | TAOK2 | 2.04550302 |
| 15 | SMG1 | 2.02024179 |
| 16 | RIPK1 | 2.00157714 |
| 17 | RIPK4 | 1.90359434 |
| 18 | BMX | 1.85955827 |
| 19 | MAP3K10 | 1.83872990 |
| 20 | MET | 1.81136295 |
| 21 | TGFBR2 | 1.73832363 |
| 22 | IRAK4 | 1.71109993 |
| 23 | TBK1 | 1.68077122 |
| 24 | TAOK1 | 1.65427650 |
| 25 | MAP4K1 | 1.60400908 |
| 26 | PAK4 | 1.59376393 |
| 27 | CAMK1D | 1.56557951 |
| 28 | CDK12 | 1.55931363 |
| 29 | TSSK6 | 1.55437713 |
| 30 | CSK | 1.54314712 |
| 31 | BCKDK | 1.53895508 |
| 32 | SCYL2 | 1.41508133 |
| 33 | EPHB1 | 1.40946452 |
| 34 | PASK | 1.40518703 |
| 35 | FGFR4 | 1.39134703 |
| 36 | MAP3K1 | 1.34446463 |
| 37 | GRK6 | 1.30958046 |
| 38 | MAP3K14 | 1.30948292 |
| 39 | RPS6KB2 | 1.30874856 |
| 40 | LRRK2 | 1.29087877 |
| 41 | STK10 | 1.28955304 |
| 42 | PDGFRA | 1.26540660 |
| 43 | FGR | 1.25368844 |
| 44 | NME2 | 1.23337490 |
| 45 | MAP3K8 | 1.15171816 |
| 46 | MAP2K2 | 1.14526581 |
| 47 | TTK | 1.14285589 |
| 48 | KDR | 1.13293731 |
| 49 | KSR2 | 1.12405530 |
| 50 | ARAF | 1.11723560 |
| 51 | EEF2K | 1.11475533 |
| 52 | CDC42BPA | 1.10865381 |
| 53 | PDPK1 | 1.10772802 |
| 54 | MAP3K13 | 1.09427348 |
| 55 | LATS2 | 1.07983151 |
| 56 | INSRR | 1.07695400 |
| 57 | NEK2 | 1.07381321 |
| 58 | WEE1 | 1.07316024 |
| 59 | TTN | 1.06792370 |
| 60 | PRKD2 | 1.06030225 |
| 61 | NEK9 | 1.04750402 |
| 62 | NEK1 | 1.00043009 |
| 63 | MTOR | 0.99826608 |
| 64 | MARK2 | 0.98981072 |
| 65 | CDK7 | 0.98875502 |
| 66 | CDK4 | 0.98652539 |
| 67 | MAP3K6 | 0.98029359 |
| 68 | FES | 0.95407476 |
| 69 | SIK3 | 0.95159295 |
| 70 | TGFBR1 | 0.94420733 |
| 71 | ZAP70 | 0.90977104 |
| 72 | MAP2K3 | 0.89859629 |
| 73 | TNK2 | 0.89679388 |
| 74 | PTK6 | 0.89128235 |
| 75 | IRAK2 | 0.88038814 |
| 76 | PTK2 | 0.86515023 |
| 77 | ZAK | 0.84772957 |
| 78 | CDK6 | 0.84702462 |
| 79 | RPS6KA2 | 0.84082182 |
| 80 | MAPKAPK3 | 0.83635136 |
| 81 | TRPM7 | 0.82791868 |
| 82 | STK38L | 0.80847299 |
| 83 | CSF1R | 0.79027235 |
| 84 | HCK | 0.78508724 |
| 85 | IKBKE | 0.76317339 |
| 86 | ILK | 0.74260325 |
| 87 | PIM2 | 0.73569804 |
| 88 | DDR2 | 0.72883104 |
| 89 | ALK | 0.71981625 |
| 90 | TEC | 0.71831942 |
| 91 | RPS6KL1 | 0.71630415 |
| 92 | RPS6KC1 | 0.71630415 |
| 93 | PDK1 | 0.70598463 |
| 94 | TYK2 | 0.70371957 |
| 95 | SIK1 | 0.70231253 |
| 96 | MATK | 0.69095042 |
| 97 | PAK1 | 0.68910871 |
| 98 | MAP2K1 | 0.68554956 |
| 99 | BRD4 | 0.66605361 |
| 100 | JAK1 | 0.65113175 |
| 101 | PIM1 | 0.64747836 |
| 102 | MAP3K2 | 0.64327129 |
| 103 | MST1R | 0.60704571 |
| 104 | BTK | 0.60204869 |
| 105 | GRK1 | 0.59863192 |
| 106 | PRKCI | 0.58518704 |
| 107 | AKT3 | 0.57890954 |
| 108 | PAK2 | 0.57538219 |
| 109 | RPS6KA4 | 0.56534248 |
| 110 | DYRK3 | 0.56481533 |
| 111 | PRKD3 | 0.56006039 |
| 112 | JAK2 | 0.54786915 |
| 113 | PLK1 | 0.52786712 |
| 114 | DMPK | 0.52231781 |
| 115 | MAP3K3 | 0.52169981 |
| 116 | STK38 | 0.50623996 |
| 117 | CAMK1G | 0.50223753 |
| 118 | AURKA | 0.50148346 |
| 119 | RPS6KA6 | 0.50096333 |
| 120 | MAPK11 | 0.50020446 |
| 121 | HIPK2 | 0.48931298 |
| 122 | ABL2 | 0.48755076 |
| 123 | MOS | 0.48722708 |
| 124 | RET | 0.48588498 |
| 125 | FGFR1 | 0.48190626 |
| 126 | MAPK12 | 0.47562915 |
| 127 | CDC7 | 0.46880116 |
| 128 | ICK | 0.46858298 |
| 129 | STK24 | 0.46589692 |
| 130 | AKT2 | 0.46059856 |
| 131 | MAP3K5 | 0.45895878 |
| 132 | LYN | 0.45700353 |
| 133 | GRK7 | 0.45532101 |
| 134 | TESK1 | 0.44912047 |
| 135 | IKBKB | 0.44119042 |
| 136 | MAPKAPK2 | 0.41854738 |
| 137 | NTRK1 | 0.41820405 |
| 138 | STK4 | 0.38879720 |
| 139 | IRAK1 | 0.38836138 |
| 140 | LCK | 0.38731046 |
| 141 | SYK | 0.38189160 |
| 142 | ATR | 0.38051691 |
| 143 | BRAF | 0.37911132 |
| 144 | PRKCD | 0.35879381 |
| 145 | ACVR1B | 0.33981432 |
| 146 | ADRBK2 | 0.32532811 |
| 147 | DAPK3 | 0.32146531 |
| 148 | DYRK1B | 0.31425962 |
| 149 | EGFR | 0.30963547 |
| 150 | JAK3 | 0.30837541 |
| 151 | MAPK1 | 0.30073995 |
| 152 | TESK2 | 0.29750887 |
| 153 | CDK2 | 0.28563761 |
| 154 | AURKB | 0.27976255 |
| 155 | KIT | 0.27963142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.76355667 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.62440282 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.61830313 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.46766830 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.45025963 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.43364111 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34170450 |
| 8 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.26947589 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.14309657 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.00476797 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.96833704 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.96307008 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.89591893 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87201897 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.85885955 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.85355399 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80283778 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.75463689 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.74755900 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.65348221 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.65321674 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.64720295 |
| 23 | RNA transport_Homo sapiens_hsa03013 | 1.63619343 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.57220905 |
| 25 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.57095083 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.55645000 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.54585465 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51217486 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.48057180 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.47343043 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46925223 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.46398235 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.43586902 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.43116678 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42037822 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38579605 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38144187 |
| 38 | Proteasome_Homo sapiens_hsa03050 | 1.37807792 |
| 39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.26516858 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26418343 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.25525880 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21583390 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19465430 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.18053163 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17763693 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17510486 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16844081 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16688416 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15419125 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14161457 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.13639606 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12724467 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11866989 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 1.09562262 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09486300 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 1.08299679 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 1.06886413 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 1.06838501 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 1.06566585 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04026400 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02521726 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 1.01871688 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01642546 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 1.00344686 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97132010 |
| 66 | Bladder cancer_Homo sapiens_hsa05219 | 0.96508713 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95060894 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94386380 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.93782782 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93631956 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93540964 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93353873 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92203393 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91317923 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.91306972 |
| 76 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91114173 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90570330 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89949246 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89903863 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89004437 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.88628919 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.87267069 |
| 83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.85883934 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.85201353 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84657043 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84331939 |
| 87 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83586094 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83013143 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81292419 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80575320 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79739013 |
| 92 | Measles_Homo sapiens_hsa05162 | 0.78944184 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78037707 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77893287 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77524065 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77486472 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.76727736 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73476207 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72932468 |
| 100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72623014 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70305720 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70228475 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70011267 |
| 104 | Spliceosome_Homo sapiens_hsa03040 | 0.69487626 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69347781 |
| 106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69303421 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.68631107 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67878427 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67329299 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.67240943 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66743709 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66426462 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66402222 |
| 114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.64792556 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64657106 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.64429892 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.64003742 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62928447 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62414873 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.61967611 |
| 121 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61925968 |
| 122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61434739 |
| 123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60460121 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60044580 |
| 125 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56847882 |
| 126 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56093696 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56018193 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.55492361 |
| 129 | Peroxisome_Homo sapiens_hsa04146 | 0.54684193 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54665089 |
| 131 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54559252 |
| 132 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53228432 |
| 133 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53146495 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52677718 |
| 135 | Asthma_Homo sapiens_hsa05310 | 0.52133149 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51341917 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.51244403 |
| 138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50907375 |
| 139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50736906 |
| 140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48308967 |
| 141 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48265783 |
| 142 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47653312 |
| 143 | Glioma_Homo sapiens_hsa05214 | 0.47574223 |
| 144 | Prostate cancer_Homo sapiens_hsa05215 | 0.47558414 |
| 145 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46336220 |
| 146 | ABC transporters_Homo sapiens_hsa02010 | 0.46304303 |
| 147 | Focal adhesion_Homo sapiens_hsa04510 | 0.45778249 |
| 148 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45635400 |
| 149 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45392654 |
| 150 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43862623 |
| 151 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42521260 |
| 152 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42191844 |
| 153 | Leishmaniasis_Homo sapiens_hsa05140 | 0.39346352 |
| 154 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39155910 |
| 155 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38937034 |
| 156 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38833046 |
| 157 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38783835 |
| 158 | Melanoma_Homo sapiens_hsa05218 | 0.38583024 |
| 159 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38098778 |
| 160 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.37229897 |
| 161 | Lysine degradation_Homo sapiens_hsa00310 | 0.37072517 |
| 162 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36735127 |
| 163 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35767471 |

